In the press release by BioElectronics Corporation, we read about the ActiPatch device.
The website explains:
ActiPatch Therapy is a convenient, cost-effective pulsed electromagnetic device indicated for the treatment of edema following blepharoplasty [“surgery of the eyelids” — ed.].
For decades, physicians and therapists worldwide have prescribed pulsed electromagnetic field (PEMF) therapy for their patients through large PEMF machines.
In America the use of pulsed electromagnetic therapy has been limited due to its high cost and the required frequency of therapy (daily multiple treatments over a varying number of days). The existing machines range in price from $7,000 to $25,000 and treatment must be administered by a trained operator.
ActiPatch has overcome the prohibitive limitations of those large PEMF machines. It captures their equivalent therapeutic power but delivers it within a miniaturized, portable and inexpensive patch sized device. Years of scientific research combined with quantum advances in microelectronics, has led to the development and introduction of this small yet powerful therapeutic remedy.
The device has been approved by FDA specifically for eye-lid surgery.
ActiPatch Model 375 with the area of its effectiveness is shown in the picture above.
More at BioElectronics…